Atyr Pharma Inc
Atyr Pharma Inc (ATYR) Implied Volatility Current
ATYR implied volatility is 576%. IV Rank is 92%, placing current premiums in the top of their 52-week range.
Read more
Tracking ATYR implied volatility helps you identify when options premiums on Atyr Pharma Inc are historically cheap or expensive, and where the best trades are hiding. Atyr Pharma Inc implied volatility reflects the market's expectation of future price movement: when ATYR IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Atyr Pharma Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ATYR, tracking metrics like ATYR IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ATYR signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders.
It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ATYR implied volatility sits today versus where it has been. Our scanner ranks Atyr Pharma Inc implied volatility against its historical range, surfaces extremes in ATYR IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Atyr Pharma Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is near its yearly peak - premiums are expensive, favoring sellers.
As of September 23, 2026
Trade options with IV on your side
Track ATYR IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→